Prognostic Performance of TAPSE/sPAP Versus RV/LV Ratio in Normotensive Acute Pulmonary Embolism
Journal of Clinical Medicine · 10.11.2026 · 15 (22) · 8790
DOI: 10.3390/jcm15228790 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 10.11.2026. Verfasst von Michał Ciurzyński und 9 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Normotensive patients with acute pulmonary embolism (APE) represent a heterogeneous population with variable early mortality. The tricuspid annular plane systolic excursion to systolic pulmonary artery pressure ratio (TAPSE/sPAP), an echocardiographic marker of right ventricular–pulmonary arterial coupling, has shown prognostic value in APE, but comparisons with established indices of right ventricular dysfunction remain limited.
Objectives
To assess and compare the prognostic value of TAPSE/sPAP and the right-to-left ventricular diameter ratio (RV/LV) for predicting in-hospital all-cause mortality or hemodynamic deterioration in initially normotensive patients with APE.
Methods
We retrospectively analyzed prospectively collected registry data from 401 initially normotensive patients with APE who underwent echocardiography within 24 h of admission and had an available TAPSE/sPAP measurement. The clinical endpoint was a composite of in-hospital all-cause mortality and a complicated in-hospital course. TAPSE/sPAP was first evaluated in the full cohort; head-to-head comparisons with RV/LV used the complete-case cohort.
Results
The clinical endpoint occurred in 25 patients (6.2%). In the full cohort, lower TAPSE/sPAP was associated with the endpoint (HR: 3.77; 95% CI: 1.78–7.99 per 1-SD decrease). Head-to-head analyses included 354 patients and 23 events; the C-index was 0.721 for TAPSE/sPAP and 0.731 for RV/LV. In the mutually adjusted model, TAPSE/sPAP remained associated with the endpoint (HR: 1.36; 95% CI: 1.06–1.75 per 0.1 decrease; p = 0.017), whereas RV/LV was not (HR: 1.09; 95% CI: 0.95–1.26 per 0.1 increase; p = 0.206).
Conclusions
TAPSE/sPAP is associated with adverse in-hospital outcomes in normotensive patients with APE but does not provide superior prognostic discrimination compared with RV/LV.
Zitieren
APA
Ciurzyński, M., Perzanowska-Brzeszkiewicz, K., Jermakow, M., Dzikowska-Diduch, O., Behrendt, J., Filipiak, J., Kuryła, M., Karolak, B., Machowski, M., & Pruszczyk, P. (2026). Prognostic Performance of TAPSE/sPAP Versus RV/LV Ratio in Normotensive Acute Pulmonary Embolism. Journal of Clinical Medicine, 15(22), 8790. https://doi.org/10.3390/jcm15228790
Vancouver
Ciurzyński M, Perzanowska-Brzeszkiewicz K, Jermakow M, Dzikowska-Diduch O, Behrendt J, Filipiak J, et al. Prognostic Performance of TAPSE/sPAP Versus RV/LV Ratio in Normotensive Acute Pulmonary Embolism. Journal of Clinical Medicine. 2026;15(22):8790. doi:10.3390/jcm15228790
BibTeX
@article{Ciurzyski2026,
author = {Ciurzyński, Michał and Perzanowska-Brzeszkiewicz, Katarzyna and Jermakow, Mateusz and Dzikowska-Diduch, Olga and Behrendt, Jan and Filipiak, Jakub and Kuryła, Martyna and Karolak, Bartosz and Machowski, Michał and Pruszczyk, Piotr},
title = {Prognostic Performance of TAPSE/sPAP Versus RV/LV Ratio in Normotensive Acute Pulmonary Embolism},
journal = {Journal of Clinical Medicine},
year = {2026},
volume = {15},
number = {22},
pages = {8790},
doi = {10.3390/jcm15228790}
}
EUVIMED